Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Practichem
AddedFeb 16, 2024
UpdatedJun 18, 2026
Practichem

Practichem

Seed

Practichem: Simplifying complex biotech research with innovative tools, promoting open science.

HQ
Raleigh, NC, US
Founded
2010
Overview
Compare
Fundraising
Employees
Website

Practichem, founded in Raleigh, is dedicated to simplifying complex biotech research through innovative tools and promoting open science. The company focuses on making biotech research more accessible to diverse backgrounds by providing collaborative protein purification systems. Their products, which include chromatography instruments, enable scientists to share buffer recipes, columns, and methods, fostering a collective intelligence approach to biotech research.

Notable figures affiliated with Practichem include key investors and advisors from the biotech and scientific communities. The company has achieved significant milestones by offering affordable and user-friendly solutions that enhance research efficiency. Practichem's impact lies in democratizing access to advanced biotech tools, thereby accelerating scientific discoveries and fostering a more inclusive research environment.

Practichem - Similar Companies

Q Biotech logo

Q Biotech

q-biotech.com

Proteios Technology logo

Proteios Technology

proteios.com

MolecularCloud logo

MolecularCloud

molecularcloud.org

ChemRar logo

ChemRar

chemrar.ru

FlowDeploy logo

FlowDeploy

trytoolchest.com

Scientist.com logo

Scientist.com

scientist.com

Qatch Technologies logo

Qatch Technologies

qatchtech.com

Cayman Chemical Company logo

Cayman Chemical Company

Versametrics logo

Versametrics

LabGrid logo

LabGrid

Insightful Science logo

Insightful Science

Benchling logo

Benchling

benchling.com

Agile Sciences logo

Agile Sciences

agilesci.com

Lamin logo

Lamin

lamin.ai

Zageno logo

Zageno

Practichem - Quick Facts

Who are Practichem's competitors?

Companies similar to Practichem include Q Biotech, Proteios Technology, MolecularCloud and ChemRar.

When was Practichem founded?

Practichem was founded in 2010.

Where is Practichem's headquarters located?

Practichem's headquarters is located in Raleigh, NC, US.

When was Practichem's last funding round?

Practichem's most recent funding round was for $5M (USD) in April 2016.

How much has Practichem raised to-date?

As of Apr 28, 2016, Practichem has raised a total of $5M (USD).

How many employees does Practichem have?

Practichem has 11 employees as of Feb 4, 2024.

Practichem - Classification

Ownership
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Recurring
  • Transactional
Main Product
  • Biotech Tools
Tags
  • Hardware
  • SaaS
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541500Computer Systems Design and Related Services
  • 541000Professional, Scientific, and Technical Services
  • 541510Computer Systems Design and Related Services
  • 541511Custom Computer Programming Services
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7371Computer Programming Services
Show 5 more industry codes
NAICS
  • 513200Software Publishers
  • 510000Information
  • 513000Publishing Industries
  • 513210Software Publishers
SIC
  • 7372Prepackaged Software